Mon 21 February 2011, Financial Times

Japan’s KHK bids £292m for ProStrakan

By Andrew Bolger
The board of ProStrakan , a speciality pharmaceutical company based in the Scottish borders, is recommending a £292m cash offer from Tokyo-based Kyowa Hakko Kirin (KHK).

Similar articles

(what's this?)

ordered by similarity (order by date)